{"id":12316,"date":"2024-08-27T07:45:00","date_gmt":"2024-08-27T05:45:00","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12316"},"modified":"2026-03-03T09:47:01","modified_gmt":"2026-03-03T08:47:01","slug":"medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/","title":{"rendered":"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise"},"content":{"rendered":"\n

The 11th representative survey carried out by gfs.bern on behalf of Interpharma shows that the Swiss population remains convinced of the benefits of the bilateral agreements. The electorate see the bilateral agreements as the best option for regulating relations with the EU. They see the current negotiations as highly important for innovation and prosperity in Switzerland. They support the efforts of the Federal Council \u2013 and they are willing to compromise in the interests of successful negotiations.<\/p>\n\n\n\n

For the eleventh time, Interpharma \u2013 the association of Switzerland\u2019s research-based pharmaceutical companies \u2013 has commissioned gfs.bern to conduct a representative survey on relations between Switzerland and the EU. And for the eleventh year in succession, the Swiss population has shown that they are strongly committed to the bilateral path. The general view of the bilateral agreements has grown even more positive in comparison with previous surveys. Currently, a clear majority (65%) see mainly benefits in the bilateral path \u2013 the highest rate since the surveys began. Markedly fewer respondents than last year are neutral, and can see both advantages and disadvantages in cooperation with the EU (14%, -9 percentage points). The Federal Council\u2019s resumption of negotiations has noticeably heightened discourse among the population and increasingly prompted clear positioning.<\/p>\n\n\n\n

Ren\u00e9 Buholzer, CEO of Interpharma, said:<\/p>\n\n\n\n

\n

\u201cDespite some strong criticism in the media and political discourse regarding the negotiations with the EU, the population seems to be significantly more clear-eyed. There is an undeniable desire for regulated relations with the EU. So it is also not surprising that more voters than at any time in the last ten years see advantages in the bilateral agreements.\u201d<\/em><\/em><\/p>\n<\/blockquote>\n\n\n\n

Clear affirmation of the benefits of the bilateral agreements<\/strong><\/strong><\/h2>\n\n\n\n

As in previous years, a majority is in favor of negotiations with the EU. Here respondents saw particular benefits for the Swiss economy (86%), for Switzerland as a research hub (83%), and for working (70%) and studying (69%) in Europe. The population is also aware that the bilateral agreements will give Switzerland access to the export market (84%), to educational and research programs (82%) and to skilled workers from other countries (79%). For the Swiss, the vital role of the bilateral agreements for Switzerland\u2019s prosperity and innovation is clear, once again confirming a position that has been consolidated for years.<\/p>\n\n\n\n

Ren\u00e9 Buholzer, CEO of Interpharma, commented:<\/p>\n\n\n\n

\n

\u201cThe prosperity of Switzerland is greatly dependent on its economic relations with other countries. Because a strong research hub with great innovative energy is something we can\u2019t achieve alone \u2013 consequently voters are firmly in favor of cooperation with the EU, our most important trading partner.\u201d<\/em><\/em><\/p>\n<\/blockquote>\n\n\n\n

Voters: willing to compromise<\/strong><\/strong><\/h2>\n\n\n\n

Almost four out of five respondents think it is right that negotiations with the EU are starting up again. Voters value the bilateral agreements and don\u2019t want to jeopardize them. But they are also clear that successfully moving the bilateral agreements forward will take concessions. Since last year there has been a markedly sharp increase in the willingness to compromise on the retention of current protections against wage dumping. In the interests of reaching an agreement, 85% of respondents (+30 percentage points) were prepared to compromise on wage protection. While not yet a majority, there was also a sharp increase in willingness to compromise on adoption of Union citizenship (47%, +16 percentage points). And for the first time, a majority is in favor of continuing with the bilateral agreements even if it is associated with the adoption of EU law (55%). Voters also declared their willingness to compromise on opening up the Swiss electricity market and recognizing the EU Court of Justice for dispute resolution.<\/p>\n","protected":false},"excerpt":{"rendered":"

The 11th representative survey carried out by gfs.bern on behalf of Interpharma shows that the Swiss population remains convinced of the benefits of the bilateral agreements. The electorate see the bilateral agreements as the best option for regulating relations with the EU. They see the current negotiations as highly important for innovation and prosperity in […]<\/p>\n","protected":false},"author":1,"featured_media":3149,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[121],"class_list":["post-12316","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-medienmitteilung-en"],"acf":[],"yoast_head":"\nMedia Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise\" \/>\n<meta property=\"og:description\" content=\"The 11th representative survey carried out by gfs.bern on behalf of Interpharma shows that the Swiss population remains convinced of the benefits of the bilateral agreements. The electorate see the bilateral agreements as the best option for regulating relations with the EU. They see the current negotiations as highly important for innovation and prosperity in […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-27T05:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T08:47:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1731\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise\",\"datePublished\":\"2024-08-27T05:45:00+00:00\",\"dateModified\":\"2026-03-03T08:47:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/\"},\"wordCount\":605,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"keywords\":[\"Medienmitteilungen\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/\",\"url\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/\",\"name\":\"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"datePublished\":\"2024-08-27T05:45:00+00:00\",\"dateModified\":\"2026-03-03T08:47:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"width\":2560,\"height\":1731},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/","og_locale":"en_US","og_type":"article","og_title":"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise","og_description":"The 11th representative survey carried out by gfs.bern on behalf of Interpharma shows that the Swiss population remains convinced of the benefits of the bilateral agreements. The electorate see the bilateral agreements as the best option for regulating relations with the EU. They see the current negotiations as highly important for innovation and prosperity in […]","og_url":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/","og_site_name":"Interpharma","article_published_time":"2024-08-27T05:45:00+00:00","article_modified_time":"2026-03-03T08:47:01+00:00","og_image":[{"width":2560,"height":1731,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"Written by":"berta_admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise","datePublished":"2024-08-27T05:45:00+00:00","dateModified":"2026-03-03T08:47:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/"},"wordCount":605,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","keywords":["Medienmitteilungen"],"inLanguage":"en-US","copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/","url":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/","name":"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","datePublished":"2024-08-27T05:45:00+00:00","dateModified":"2026-03-03T08:47:01+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","width":2560,"height":1731},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/en\/blog\/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Media Release: Europe survey 2024: the Swiss electorate backs the bilateral path and is open to compromise"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/comments?post=12316"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12316\/revisions"}],"predecessor-version":[{"id":12317,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12316\/revisions\/12317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media\/3149"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media?parent=12316"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/tags?post=12316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}